Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica
- PMID: 15871111
- DOI: 10.1086/428850
Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica
Abstract
Background: Detailed epidemiologic studies of cervical type-specific human papillomavirus (HPV) infection in large populations are scarce.
Methods: We recruited a population-based cohort in Guanacaste, Costa Rica. Participants were interviewed, screened for cervical neoplasia, and tested for >40 HPV types by use of MY09/11 L1 consensus primer polymerase chain reaction. We estimated the risk factors for infection and the associations between type-specific HPV infections and cervical intraepithelial neoplasia (CIN) and cancer in 8514 sexually active women who had not undergone a hysterectomy.
Results: The overall HPV prevalence was 26.5%. The most common type was HPV-16 (3.6% of the population). HPV prevalence showed a U-shaped age-specific curve. Sexual behaviors were the main determinants of oncogenic and nononcogenic infections; age at first sexual intercourse was not independently associated with infection. Barrier contraceptive use was somewhat protective against infection. Oncogenic infections were strongly associated with risk of all grades of CIN and of cancer. Types 16, 18, and 58 were the most common in women diagnosed with CIN3 and cancer. Except for those that included HPV-16, multiple-type infections were associated with an increased risk (compared with that for single-type infections) of all grades of CIN and of cancer.
Conclusions: We confirmed the bimodal age pattern of HPV infection in Guanacaste and the sexually transmitted nature of both oncogenic and nononcogenic HPV types.
Comment in
-
Human papillomavirus through the ages.J Infect Dis. 2005 Jun 1;191(11):1787-9. doi: 10.1086/430275. Epub 2005 May 2. J Infect Dis. 2005. PMID: 15871108 No abstract available.
Similar articles
-
Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types.Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1394-9. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12433717
-
Age-related changes of the cervix influence human papillomavirus type distribution.Cancer Res. 2006 Jan 15;66(2):1218-24. doi: 10.1158/0008-5472.CAN-05-3066. Cancer Res. 2006. PMID: 16424061
-
A population-based study of vaginal human papillomavirus infection in hysterectomized women.J Infect Dis. 2004 Aug 1;190(3):458-67. doi: 10.1086/421916. Epub 2004 Jul 2. J Infect Dis. 2004. PMID: 15243917
-
Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia.Vaccine. 2008 Aug 19;26 Suppl 10:K1-16. doi: 10.1016/j.vaccine.2008.05.064. Vaccine. 2008. PMID: 18847553 Review.
-
Human papillomavirus: the burden of infection.Obstet Gynecol Surv. 2006 Jun;61(6 Suppl 1):S3-14. doi: 10.1097/01.ogx.0000221010.82943.8c. Obstet Gynecol Surv. 2006. PMID: 16729902 Review.
Cited by
-
HPV16 CpG methyl-haplotypes are associated with cervix precancer and cancer in the Guanacaste natural history study.Gynecol Oncol. 2015 Jul;138(1):94-100. doi: 10.1016/j.ygyno.2015.05.001. Epub 2015 May 19. Gynecol Oncol. 2015. PMID: 26001326 Free PMC article.
-
Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study.BMC Cancer. 2009 Aug 7;9:275. doi: 10.1186/1471-2407-9-275. BMC Cancer. 2009. PMID: 19664216 Free PMC article.
-
Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.J Natl Cancer Inst. 2010 Mar 3;102(5):315-24. doi: 10.1093/jnci/djq001. Epub 2010 Feb 15. J Natl Cancer Inst. 2010. PMID: 20157096 Free PMC article.
-
Human papillomavirus genotype specificity of hybrid capture 2.J Clin Microbiol. 2008 Aug;46(8):2595-604. doi: 10.1128/JCM.00824-08. Epub 2008 Jun 25. J Clin Microbiol. 2008. PMID: 18579716 Free PMC article.
-
Three-year risk of cervical precancer and cancer after the detection of low-risk human papillomavirus genotypes targeted by a commercial test.Obstet Gynecol. 2014 Jan;123(1):49-56. doi: 10.1097/AOG.0000000000000013. Obstet Gynecol. 2014. PMID: 24463663 Free PMC article.